To measure the functional accuracy, sensitivity and specificity, Cohort II of 53 genomic DNA reference materials with positive cancer history and known pathogenic/likely pathogenic variants in APC, ATM, BRCA1, BRCA2, CDKN2A, MEN1 and PTEN were sequenced. The gene discussed is BRCA2; the disease is cancer.